Reneo Pharmaceuticals Inc. Gains 952.02%
Thu, Oct 10, 2024 at 07:49 PM
Reneo Pharmaceuticals Inc. (RPHM:NASDAQ) rocketted at $18.2, representing a gain of 952%. The stock appeared on our News Catalysts scanner on Mon, Oct 07, 2024 at 07:28 AM in the 'MERGER' category. From Thu, Sep 26, 2024, the stock recorded 60.00% Up Days and 81.82% Green Days
About Reneo Pharmaceuticals Inc. (RPHM:NASDAQ)
Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company.
Top 10 Gainers:
- Reneo Pharmaceuticals Inc. (RPHM:NASDAQ), 952.02%
- SRAX, Inc. (SRAX:NASDAQ), 90.48%
- BloomZ Inc. (BLMZ:NASDAQ), 87.36%
- MicroAlgo Inc. (MLGO:NASDAQ), 48.65%
- Surf Air Mobility Inc. (SRFM:NYSE), 40.34%
- XChange TEC.INC American Depositary Shares (XHG:NASDAQ), 39.39%
- CN Energy Group Inc. (CNEY:NASDAQ), 36.38%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 34.85%
- A2Z Smart Technologies Corp. (AZ:NASDAQ), 34.34%
- Galaxy Payroll Group Limited (GLXG:NASDAQ), 33.77%